Ralliant Corporation $RAL Position Boosted by Dimensional Fund Advisors LP

Key Points

• Dimensional Fund Advisors increased its Ralliant stake by 60.6% in the first quarter, purchasing 496,171 additional shares to hold 1.31 million shares worth approximately $54.7 million.
• Ralliant reported quarterly adjusted EPS of $0.68, beating the $0.63 consensus estimate, on revenue of about $567.8 million. The company guided to fiscal 2026 EPS of $2.76–$2.90 and third-quarter EPS of $0.72–$0.78.
• Analyst sentiment remains broadly positive, with a consensus “Moderate Buy” rating and an average price target of $75.70, although valuation, reported profitability, and execution risks remain concerns.

Dimensional Fund Advisors LP lifted its holdings in Ralliant Corporation (NYSE:RAL - Free Report) by 60.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,314,834 shares of the company's stock after purchasing an additional 496,171 shares during the period. Dimensional Fund Advisors LP owned about 1.17% of Ralliant worth $54,669,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in RAL. Allworth Financial LP lifted its stake in Ralliant by 134.4% during the fourth quarter. Allworth Financial LP now owns 511 shares of the company's stock valued at $26,000 after purchasing an additional 293 shares during the last quarter. Rothschild Investment LLC grew its position in Ralliant by 98.1% in the fourth quarter. Rothschild Investment LLC now owns 612 shares of the company's stock worth $31,000 after buying an additional 303 shares during the last quarter. Keybank National Association OH increased its holdings in shares of Ralliant by 1.6% in the fourth quarter. Keybank National Association OH now owns 19,667 shares of the company's stock valued at $1,001,000 after buying an additional 305 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Ralliant by 49.6% during the 4th quarter. UMB Bank n.a. now owns 983 shares of the company's stock valued at $50,000 after acquiring an additional 326 shares during the last quarter. Finally, Maryland State Retirement & Pension System lifted its position in shares of Ralliant by 1.5% during the 4th quarter. Maryland State Retirement & Pension System now owns 21,940 shares of the company's stock valued at $1,117,000 after acquiring an additional 329 shares during the last quarter.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Zacks Research upgraded Ralliant from a "hold" rating to a "strong-buy" rating in a report on Tuesday, June 30th. Morgan Stanley upped their target price on Ralliant from $68.00 to $85.00 and gave the company an "overweight" rating in a report on Tuesday, June 23rd. Evercore assumed coverage on Ralliant in a research report on Tuesday, June 9th. They issued an "outperform" rating and a $80.00 price target for the company. TD Cowen lifted their price target on Ralliant from $70.00 to $80.00 and gave the stock a "buy" rating in a research note on Friday. Finally, Vertical Research downgraded Ralliant from a "buy" rating to a "hold" rating and set a $65.00 price objective on the stock. in a report on Wednesday, May 27th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $75.70.

Ralliant Stock Performance

Shares of RAL stock opened at $65.78 on Friday. The company has a market capitalization of $7.36 billion and a price-to-earnings ratio of -6.06. Ralliant Corporation has a 1-year low of $37.27 and a 1-year high of $75.41. The company has a current ratio of 1.52, a quick ratio of 1.05 and a debt-to-equity ratio of 0.75. The stock's fifty day simple moving average is $67.20 and its 200-day simple moving average is $54.34.

Ralliant (NYSE:RAL - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.63 by $0.05. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.The firm had revenue of $567.80 million during the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, sell-side analysts predict that Ralliant Corporation will post 2.88 earnings per share for the current fiscal year.

Ralliant Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 8th were given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend was Monday, June 8th. Ralliant's dividend payout ratio is -1.83%.

Ralliant News Roundup

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Quarterly results exceeded expectations: Ralliant reported second-quarter revenue of approximately $568 million, up 13% year over year, and adjusted EPS of $0.68 versus the $0.63 consensus estimate. Adjusted net earnings were $76 million, while net earnings were $57 million. Ralliant Reports Second Quarter 2026 Results and Raises Full Year Guidance
• Positive Sentiment: Full-year and third-quarter outlooks topped consensus: Ralliant guided third-quarter EPS to $0.72-$0.78 and revenue to $570 million-$590 million, above analyst estimates of $0.68 and $556.4 million, respectively. Full-year 2026 adjusted EPS guidance was raised to $2.76-$2.90 from an analyst consensus of $2.65, with revenue expected around $2.25 billion-$2.30 billion. Ralliant forecasts 2026 revenue and productivity savings
• Positive Sentiment: Cost-reduction efforts could support future margins: Ralliant’s enterprise productivity program is targeting $50 million-$60 million in annualized run-rate savings by 2028, providing a potential boost to earnings and cash flow.
• Positive Sentiment: Analysts raised targets: Citigroup increased its target to $82 and initiated a “buy” rating, Truist raised its target to $82 while reaffirming “buy,” and RBC lifted its target to $73 while maintaining a “sector perform” rating. These targets imply meaningful upside from the recent trading level. Benzinga analyst actions
• Neutral Sentiment: Trading volatility increased: RAL experienced a temporary limit-up/limit-down trading pause during the earnings session, signaling elevated short-term volatility rather than a fundamental change in the business.
• Negative Sentiment: Valuation and execution risks remain: Despite the adjusted earnings beat, investors may continue to focus on Ralliant’s reported profitability, integration or productivity-program execution, and the gap between the stock’s recent price and analyst targets.

Ralliant Company Profile

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RAL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.